13-3406(A)(7) The indictment alleges that between January 1, 2026, and April 28, 2026, Holladay obtained money, business, or customers through fraudulent pretenses, including failing to disclose that she was not a licensed medical provider, that SlimSlays had no licensed medical provider authorized to prescribe prescription-only drugs, and that the business had no state-licensed medical director providing legally-mandated clinical oversight
Higher-priced brands are leading the way for branded products To win, companies need to have the right marketing, the right channels, the right products, and a differentiator
In some embodiments, the amount of thermoreversible polymer (e.g., pluronic F127) in any formulation described herein is about 20% of the total weight of the formulation
Intrinsic factor autoantibodies by luminescent immuno-precipitation system in patients with corpus atrophic gastritis